Immunogenicity assay for an RNAi therapeutic (small interfering RNA) on the MSD platform

Syngene’s MSD-based ADA assay enabled sensitive, drug-tolerant immunogenicity assessment for a clinical siRNA therapeutic in regulated studies. Learn more.